Skip to content

t:connect Mobile Application, Mobile Bolus Enabled (iOS) 1007111Recalls & reported problems

Tandem Diabetes Care, Inc. · t:connect Mobile Application, Mobile Bolus Enabled, 2.x (iOS) · Class 2

Adverse event reports
3
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 90850018992452), received between Sep 9, 2022 and Mar 6, 2024 — classified as 2 injuries, 1 malfunction.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2

Patient problems

  • Hypoglycemia2
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 6, 2024

    TANDEM DIABETES RELEASED NEW T:CONNECT IOS SOFTWARE THAT INCREASED INSULIN PUMP POWER USE. TANDEM DIABETES HAS NOT NOTIFIED USERS OF DEFECTIVE SOFTWARE. THIS REPORT IS TO URGE FDA TO INVESTIGATE COMMUNICATION PRACTICES OF TANDEM DIABETES AND REQUIRE MUCH MORE TRANSPARENCY. REFERENCE REPORT: MW5152428.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18856049 ↗
  • InjuryJun 23, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE CONTACT ACCIDENTALLY REQUESTED AND DELIVERED A 3 UNIT BOLUS VIA THE T:CONNECT MOBILE APPLICATION INSTEAD OF A BOLUS FOR 3 GRAMS OF CARBOHYDRATES. SUBSEQUENTLY, CUSTOMER¿S BLOOD GLUCOSE (BG) LEVEL DECREASED TO 40 MG/DL. REPORTEDLY, THE CUSTOMER CONSUMED CARBOHYDRATES TO ADDRESS BG LEVEL. RECOMMENDATION WAS MADE TO CONSULT WITH HEALTHCARE PROVIDER REGARDING DIABETES MANAGEMENT.

    Patient problems: Hypoglycemia

    MAUDE report 17190487 ↗
  • InjurySep 9, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE CUSTOMER WENT TO THE EMERGENCY ROOM DUE TO LOW BLOOD GLUCOSE (BG) LEVEL OF 31MG/DL. THE CUSTOMER CONSUMED CARBOHYDRATES AND WAS TREATED WITH INTRAVENOUS SALINE TO ADDRESS BG LEVEL. THE CUSTOMER WAS DISCHARGED ON (B)(6) 2022 WITH NO PERMANENT INJURY. TANDEM TECHNICAL SUPPORT (CTS) REVIEWED PUMP DATA LOGS AND DETERMINED THAT THE CUSTOMER REQUESTED AND DELIVERED A 15 UNIT BOLUS VIA THE TANDEM MOBILE APPLICATION. REPORTEDLY, THE CUSTOMER HAD INTENDED TO DELIVER A 1.5 UNIT BOLUS. CTS EDUCATED THE CUSTOMER ON PROPER BOLUS DELIVERY PROCEDURE.

    Patient problems: Hypoglycemia

    MAUDE report 15396771 ↗

Other Continuous Glucose Monitor Secondary Display devices

All Continuous Glucose Monitor Secondary Display devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.